Fat dissolving injections work by destroying fat cell membranes with a synthetic form of deoxycholic acid, a bile salt your body naturally produces to break down dietary fat. When injected directly into a pocket of fat, this acid acts like a detergent, physically breaking apart the outer wall of each fat cell it contacts. The cells die, release their stored fat, and your body’s immune system clears the debris over the following weeks.
How the Injection Destroys Fat Cells
Every fat cell is surrounded by a thin membrane made of a double layer of fatty molecules called phospholipids. Deoxycholic acid is an ionic detergent, meaning it carries an electrical charge that lets it wedge itself into that fatty membrane. Its polar (water-attracting) end pushes into the membrane’s water-repelling core, destabilizing the entire structure. The proteins embedded in the membrane lose their anchoring, and the cell wall essentially collapses into tiny clusters of phospholipids and detergent molecules.
Once the membrane is gone, the fat cell dies. This process is called adipocytolysis. Earlier theories suggested the injections worked by triggering enzymes inside the cell to break down stored fat, but research has confirmed that the actual mechanism is straightforward cell destruction from the outside in. The released fat and cellular debris are then processed by your lymphatic system and liver, the same pathway your body uses to handle other waste.
Because the fat cells are permanently destroyed rather than simply shrunk, the treated area generally doesn’t regain fat in the same way. However, remaining fat cells nearby can still expand if you gain significant weight.
What Gets Injected
The only FDA-approved fat dissolving injection is Kybella, which contains 10 mg/mL of synthetic deoxycholic acid in sterile saline. It was approved in 2015 specifically for moderate to severe submental fat (the area under the chin commonly called a double chin). No other fat dissolving injection currently has FDA approval in the United States.
Outside the U.S., a product called Aqualyx is widely used in Europe, where it received regulatory clearance in 2012. It also contains deoxycholic acid but uses a different delivery system: a slow-release microgel with a sugar-based polymer that allows more gradual fat breakdown. Aqualyx is marketed for body contouring in areas beyond the chin, but it remains unapproved in the U.S.
Some clinics use older formulations that combine phosphatidylcholine (a natural fat molecule) with deoxycholic acid. Research has clarified the roles of each ingredient. Phosphatidylcholine can promote fat breakdown with relatively little inflammation, while deoxycholic acid causes more aggressive, nonspecific cell destruction and is the primary driver of both fat reduction and the swelling patients experience. Studies measuring inflammatory markers found that deoxycholic acid alone triggered intense immune responses, while phosphatidylcholine alone produced virtually none. The side effects patients experience from combination formulations are largely attributable to the deoxycholic acid component.
What a Treatment Session Looks Like
For Kybella, a provider uses a 30-gauge needle (very fine) to make a series of small injections in a grid pattern, spacing each injection point about 1 cm apart. Each injection delivers about 0.2 mL of solution at a depth of 3 to 5 mm, targeting the middle of the fat layer beneath the skin. The number of injection points depends on the size of the area, but a single session for the under-chin area typically involves 20 to 50 small injections.
Most people need more than one session. Clinical trials tested up to six sessions spaced about a month apart. Some people are satisfied after one or two treatments, while others need three or more to reach their goal. Follow-up appointments are typically spaced several weeks apart to give your body time to clear the destroyed fat cells before adding another round.
How Effective the Results Are
In phase 3 clinical trials for Kybella, 62 to 70 percent of patients achieved at least a one-grade improvement on a clinical fat rating scale, compared to roughly 20 percent in placebo groups. That one-grade change represents a visible, measurable reduction in fullness under the chin. Results aren’t instant. The body needs time to process the destroyed cells, so the visible change develops gradually over several weeks after each session.
These results are meaningful but modest. Fat dissolving injections are designed for small, localized pockets of fat, not for large-scale fat reduction or weight loss. They work best on discrete areas like the double chin, where even a small volume change creates a noticeable improvement in profile.
Common Side Effects
Because the injection literally destroys cells, the body mounts an inflammatory response to clean up the damage. This makes significant swelling and discomfort a near-universal experience, not a rare side effect. In clinical trials involving over 500 Kybella patients:
- Swelling: 87% of patients (compared to 43% with placebo injections)
- Bruising: 72% of patients
- Pain: 70% of patients
- Numbness: 66% of patients (compared to just 6% with placebo)
- Redness: 27% of patients
- Firmness or hardness at the site: 23% of patients
The swelling under the chin can be quite pronounced for the first few days and often takes one to two weeks to fully resolve. Many people describe looking like they have a worse double chin temporarily before improvement becomes visible. The numbness is also notable: two-thirds of patients experienced it, likely from the chemical’s effect on nearby sensory nerves.
Nerve Injury and Difficulty Swallowing
The under-chin area sits close to the marginal mandibular nerve, which controls muscles involved in smiling and lower lip movement. In clinical trials, 4% of Kybella patients experienced injury to this nerve, causing an uneven smile or weakness on one side of the face. All reported cases resolved on their own, but recovery ranged widely, from 1 day to nearly 10 months, with a median of 44 days.
About 2% of patients experienced difficulty swallowing, likely related to the intense swelling in the treatment area. These cases also resolved spontaneously, most within a few days (median 3 days), though some lasted up to 81 days. Both of these risks are specific to the submental area because of the anatomy involved.
Who Is a Good Candidate
Fat dissolving injections work best for people with a noticeable pocket of fat in a small area and good skin elasticity. Skin quality matters because the treatment removes volume underneath the skin. If your skin doesn’t have enough natural recoil to tighten after the fat is gone, you may be left with loose or saggy skin that looks worse than the original fullness. This is why candidates are typically between 18 and 60 years old, though age alone isn’t the deciding factor.
These injections are not a weight loss tool. They target a localized cosmetic concern. If you have a large amount of excess fat in the area, liposuction or other surgical options are likely to produce more significant results. The ideal candidate has a moderate amount of stubborn fat that hasn’t responded to diet and exercise, paired with skin firm enough to contract smoothly once the fat beneath it is reduced.